Clinically, AR agonists such as testosterone are used to treat hypogonadism and muscle wasting diseases [40], while AR antagonists like bicalutamide and enzalutamide are employed in the treatment of prostate cancer [41]. The gene discussed is AR; the disease is prostate cancer.